Shapshak P - Search Results

1

Multiple sclerosis intra-blood-brain-barrier IgG synthesis: effect of pulse intravenous and intrathecal corticosteroids.

Baumhefner RW, Tourtellotte WW, Syndulko K, Staugaitis A, Shapshak P. Baumhefner RW, et al. Among authors: shapshak p. Ital J Neurol Sci. 1989 Feb;10(1):19-32. doi: 10.1007/BF02333869. Ital J Neurol Sci. 1989. PMID: 2925343

2

The long march of the cerebrospinal fluid profile indicative of clinical definite multiple sclerosis; and still marching.

Tourtellotte WW, Baumhefner RW, Syndulko K, Shapshak P, Osborne M, Rubinshtein G, Newton L, Ellison G, Myers L, Rosario I, et al. Tourtellotte WW, et al. Among authors: shapshak p. J Neuroimmunol. 1988 Dec;20(2-3):217-27. doi: 10.1016/0165-5728(88)90163-4. J Neuroimmunol. 1988. PMID: 3198746

3

Copolymer 1 as therapy for multiple sclerosis: the cons.

Baumhefner RW, Tourtellotte WW, Syndulko K, Shapshak P, Osborne M, Rubinshtein G. Baumhefner RW, et al. Among authors: shapshak p. Neurology. 1988 Jul;38(7 Suppl 2):69-72. Neurology. 1988. PMID: 3386845 Clinical Trial.

4

The basis of intra-blood-brain-barrier IgG synthesis.

Tourtellotte WW, Staugaitis SM, Walsh MJ, Shapshak P, Baumhefner RW, Potvin AR, Syndulko K. Tourtellotte WW, et al. Among authors: shapshak p. Ann Neurol. 1985 Jan;17(1):21-7. doi: 10.1002/ana.410170107. Ann Neurol. 1985. PMID: 3985581

5

Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis.

Baumhefner RW, Tourtellotte WW, Syndulko K, Waluch V, Ellison GW, Meyers LW, Cohen SN, Osborne M, Shapshak P. Baumhefner RW, et al. Among authors: shapshak p. Arch Neurol. 1990 Jan;47(1):19-26. doi: 10.1001/archneur.1990.00530010027014. Arch Neurol. 1990. PMID: 2294889

6

Azathioprine and steroids are not more effective in decreasing multiple sclerosis intra-blood-brain-barrier IgG synthesis than steroids alone.

Staugaitis SM, Shapshak P, Myers LW, Ellison GW, Tourtellotte WW, Lee M. Staugaitis SM, et al. Among authors: shapshak p. Ann Neurol. 1985 Sep;18(3):356-7. doi: 10.1002/ana.410180316. Ann Neurol. 1985. PMID: 2996418

7

A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase.

Tourtellotte WW, Syndulko K, Baumhefner RW, Shapshak P, Osborne M. Tourtellotte WW, et al. Among authors: shapshak p. Neurology. 1988 Jul;38(7 Suppl 2):83-6. Neurology. 1988. PMID: 3386848 No abstract available.

8

Early penetration of the blood-brain-barrier by HIV.

Resnick L, Berger JR, Shapshak P, Tourtellotte WW. Resnick L, et al. Among authors: shapshak p. Neurology. 1988 Jan;38(1):9-14. doi: 10.1212/wnl.38.1.9. Neurology. 1988. PMID: 3422110

9

Advanced detection of viral nucleic acids in the central nervous system: a progress report.

Tourtellotte WW, Schmid P, Shapshak P. Tourtellotte WW, et al. Among authors: shapshak p. Riv Neurol. 1987 May-Jun;57(3):163-5. Riv Neurol. 1987. PMID: 3672008

10

Intra-blood-brain barrier IgG synthesis in cerebral cysticercosis.

Miller BL, Staugaitis SM, Tourtellotte WW, Shapshak P, Goldberg M, Heiner D, Weil M. Miller BL, et al. Among authors: shapshak p. Arch Neurol. 1985 Aug;42(8):782-4. doi: 10.1001/archneur.1985.04210090046013. Arch Neurol. 1985. PMID: 4026613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page